Phase III CASSIOPEIA Impacts Treatment Decisions in Patients With Multiple Myeloma
Pieter Sonneveld, MD, PhD, discusses how the findings from the phase III CASSIOPEIA trial inform current thinking about treating patients with multiple myeloma.